CREB1 and renal carcinoma: On the other hand, the dysregulation of cAMP signaling molecules, particularly CREB, is strongly associated with renal cancer, indicating that targeting the cAMP pathway and its downstream effectors may offer novel strategies for the prevention and treatment of this malignancy.